When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPN - Alpine Immune's ALPN-101 shows positive effects in Phase 1 in healthy volunteers
Alpine Immune Sciences Inc.
Alpine Immune Sciences (ALPN+5.4%) presents updated results from its phase 1 study of ALPN-101, dual CD28/ICOS costimulation antagonist for autoimmune and inflammatory diseases.
More news on: Alpine Immune Sciences, Inc., Healthcare stocks news,